Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 7, 1999, Pages 923-931

  Martin, Andrés ^a,b   Scahill, Lawrence ^a   Klin, Ami ^a   Volkmar, Fred R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asperger's disorder; Autism; Drug patterns; Pervasive developmental disorders; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD; DEVELOPMENTAL DISORDER; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033022811     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199907000-00024     Document Type: Article

References (34)

1. Aman MG, Van Bourgondien ME, Wolford PL, Sarphare G (1995), Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. J Am Acad Child Adolesc Psychiatry 34:1672-1681
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Bailey A, Le Couteur A, Gottesman I et al. (1995), Autism as a strongly genetic disorder: evidence from a British rain study. Psychol Med 25:63-77
4. Baltaxe CAM, Simmons JQ. (1992), A comparison of language issues in high-functioning autism and related disorders with onset in childhood and adolescence. In: High-Functioning Individuals With Autism, Schopler E, Mesibov GB, eds. New York Plenum, pp 201-226
5. Birmaher B, Quintana H, Greenhill LL (1988), Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry 27:248-251
6. Cook EH, Courchesne R, Lord C et al. (1997), Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:247-250
7. Cook EH Jr, Rowlett R, Jaselskis C, Leventhal BL (1992), Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 31:739-745
8. Eisenmajer R, Prior M, Leekam S et al. (1996), Comparison of clinical symptoms in autism and Asperger's disorder. J Am Acad Child Adolesc Psychiatry 35:1523-1531
9. Gillberg C, Ehlers S (1998), High-functioning people with autism and Asperger syndrome: a literature review. In: Asperger Syndrome or High Functioning Autism? Schopler E, Mesibov GB, Kunce LJ, eds. New York: Plenum, pp 79-106
10. Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL (1993), A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 50:441-447
11. Klin A, Volkmar FR (1997), Asperger's syndrome. In: Handbook of Autism and Pervasive Developmental Disorders, 2nd ed, Cohen DJ, Volkmar FR, eds. New York: Wiley, pp 94-112
12. Klin A, Volkmar FR, Schultz R, Pauls D, Cohen DJ (1997), Asperger's syndrome: phenomenology, neuropsychology, and neurobiology. Presented at the 44th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, October 16
13. Klin A, Volkmar FR, Sparrow SS, Cicchetti DV, Rourke BP (1995), Validity and neuropsychological characterization of Asperger syndrome: convergence with nonverbal learning disabilities syndrome. J Child Psychol Psychiatry 36:1127-1140
14. Krug DA, Arick J, Almond P (1980), Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry 21:221-229
15. McDougle CJ (1997), Psychopharmacology. In: Handbook of Autism and Pervasive Developmental Disorders, 2nd ed, Cohen DJ, Volkmar FR, eds. New York: Wiley, pp 707-729
16. McDougle CJ (1998), Repetitive thoughts and behavior in pervasive developmental disorders: phenomenology and pharmacotherapy. In: Asperger Syndrome or High Functioning Autism? Schopler E, Mesibov GB, Kunce LJ, eds. New York: Plenum, pp 293-316
17. McDougle CJ, Brodkin ES, Naylor ST, Carlson DC, Cohen DJ, Price LH (1998), Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation. J Clin Psychopharmacol 18:62-66
18. McDougle CJ, Fleischmann RL, Epperson CN, Wasylink S, Leckman JF, Price LH (1995), Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry 56:526-528
19. McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH (1996), A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53:1001-1008
20. McDougle CJ, Price LH, Volkmar FR et al. (1992), Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry 31:746-750
21. Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA (1998), Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 55:310-316
22. Ozonoff S, Rogers SJ, Pennington BF (1991), Asperger's syndrome: evidence of an empirical distinction from high-functioning autism. J Child Psychol Psychiatry 32:1107-1122
23. Potenza MN, McDougle CJ (1997), The role of serotonin in autistic-spectrum disorders. CNS Spectrums 2:25-42
24. Rourke B, Young GC, Leenaars AA (1989), A childhood learning disability that predisposes those afflicted to adolescent and adult depression and suicide risk. J Learn Disabil 22:169-185
25. Sanchez LE, Campbell M, Small AM, Cueva JE, Armenteros JL, Adams PB (1996), A pilot study of clomipramine in young autistic children. J Am Acad Child Adolesc Psychiatry 35:537-544
26. Schopler E (1996), Are autism and Asperger syndrome (AS) different labels or different disabilities? J Autism Dev Disord 26:109-110
27. Schopler E, Mesibov GB, eds (1992), High-Functioning Individuals With Autism. New York: Plenum
28. Tanguay PE, Robertson J, Derrick A (1998), A dimensional classification of autism spectrum disorder by social communication domains. J Am Acad Child Adolesc Psychiatry 37:271-277
29. Towbin K (1997), Pervasive developmental disorder not otherwise specified. In: Handbook of Autism and Pervasive Developmental Disorders, 2nd ed, Cohen DJ, Volkmar FR, eds. New York: Wiley, pp 123-147
30. Volkmar FR (1998), Categorical approaches to the diagnosis of autism. Autism 2:45-59
31. Volkmar FR, Klin A, Cohen DJ (1997), Diagnosis and classification of autism and related conditions: consensus and issues. In: Handbook of Autism and Pervasive Developmental Disorders, 2nd ed, Cohen DJ, Volkmar FR, eds. New York: Wiley, pp 5-40
32. Volkmar FR, Nelson DS (1990), Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 29:127-129
33. Volkmar FR, Sparrow SS, Rende RD, Cohen DJ (1989), Facial perception in autism. J Child Psychol Psychiatry 30:591-598
34. World Health Organization (1993), International Classification of Diseases: Diagnostic Criteria for Research, 10th ed. Geneva: World Health Organization